NCT02507440View on ClinicalTrials.gov

Impact of Topical Pharyngeal Anesthetics on Discharge of the Patients When Used in Conjunction With Propofol Sedation in Routine EGD's

PHASE4CompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

September 30, 2015

Primary Completion Date

October 31, 2016

Study Completion Date

November 30, 2016

Conditions
Topical Anesthesia
Interventions
DRUG

Lidocaine

Prior to initiation of anesthesia viscous lidocaine or placebo will be administered.

DRUG

Placebo

Prior to initiation of anesthesia viscous lidocaine or placebo will be administered.

DRUG

Propofol

All patients will receive intravenous propofol as anesthesia for EGD

Trial Locations (1)

13326

Bassett Healthcare Network, Cooperstown

Sponsors

Lead Sponsor

Bassett Healthcare
All Listed Sponsors
lead

Bassett Healthcare

OTHER

NCT02507440 - Impact of Topical Pharyngeal Anesthetics on Discharge of the Patients When Used in Conjunction With Propofol Sedation in Routine EGD's | Biotech Hunter | Biotech Hunter